Adherence to adjuvant endocrine therapy for breast cancer: importance in women with low income.
Publication
, Journal Article
Ursem, CJ; Bosworth, HB; Shelby, RA; Hwang, W; Anderson, RT; Kimmick, GG
Published in: J Womens Health (Larchmt)
May 2015
There are wide disparities in breast cancer-specific survival by patient sociodemographic characteristics. Women of lower income, for instance, have higher relapse and death rates from breast cancer. One possible contributing factor for this disparity is low use of adjuvant endocrine therapy-an extremely efficacious therapy in women with early stage, hormone receptor positive breast cancer, the most common subtype of breast cancer. Alone, adjuvant endocrine therapy decreases breast cancer recurrence by 50% and death by 30%. Data suggest that low use of adjuvant endocrine therapy is a potentially important and modifiable risk factor for poor outcome in low-income breast cancer patients.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Womens Health (Larchmt)
DOI
EISSN
1931-843X
Publication Date
May 2015
Volume
24
Issue
5
Start / End Page
403 / 408
Location
United States
Related Subject Headings
- Tamoxifen
- Socioeconomic Factors
- Public Health
- Poverty
- Neoplasm Recurrence, Local
- Medication Adherence
- Humans
- Female
- Combined Modality Therapy
- Chemotherapy, Adjuvant
Citation
APA
Chicago
ICMJE
MLA
NLM
Ursem, C. J., Bosworth, H. B., Shelby, R. A., Hwang, W., Anderson, R. T., & Kimmick, G. G. (2015). Adherence to adjuvant endocrine therapy for breast cancer: importance in women with low income. J Womens Health (Larchmt), 24(5), 403–408. https://doi.org/10.1089/jwh.2014.4982
Ursem, Carling J., Hayden B. Bosworth, Rebecca A. Shelby, Wenke Hwang, Roger T. Anderson, and Gretchen G. Kimmick. “Adherence to adjuvant endocrine therapy for breast cancer: importance in women with low income.” J Womens Health (Larchmt) 24, no. 5 (May 2015): 403–8. https://doi.org/10.1089/jwh.2014.4982.
Ursem CJ, Bosworth HB, Shelby RA, Hwang W, Anderson RT, Kimmick GG. Adherence to adjuvant endocrine therapy for breast cancer: importance in women with low income. J Womens Health (Larchmt). 2015 May;24(5):403–8.
Ursem, Carling J., et al. “Adherence to adjuvant endocrine therapy for breast cancer: importance in women with low income.” J Womens Health (Larchmt), vol. 24, no. 5, May 2015, pp. 403–08. Pubmed, doi:10.1089/jwh.2014.4982.
Ursem CJ, Bosworth HB, Shelby RA, Hwang W, Anderson RT, Kimmick GG. Adherence to adjuvant endocrine therapy for breast cancer: importance in women with low income. J Womens Health (Larchmt). 2015 May;24(5):403–408.
Published In
J Womens Health (Larchmt)
DOI
EISSN
1931-843X
Publication Date
May 2015
Volume
24
Issue
5
Start / End Page
403 / 408
Location
United States
Related Subject Headings
- Tamoxifen
- Socioeconomic Factors
- Public Health
- Poverty
- Neoplasm Recurrence, Local
- Medication Adherence
- Humans
- Female
- Combined Modality Therapy
- Chemotherapy, Adjuvant